GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $3.17 $4.17 Wednesday, 17th Apr 2024 CLRB stock ended at $3.21. This is 3.02% less than the trading day before Tuesday, 16th Apr 2024. During the day the stock fluctuated 6.48% from a day low at $3.17 to a day high of $3.37.
90 days $3.17 $4.45
52 weeks $1.33 $4.45

Historical Cellectar Biosciences prices

Date Open High Low Close Volume
2023-12-28 $2.72 $2.74 $2.46 $2.49 700 959
2023-12-27 $2.61 $2.69 $2.56 $2.60 208 683
2023-12-26 $2.76 $2.76 $2.58 $2.61 461 100
2023-12-22 $2.64 $2.68 $2.52 $2.58 385 494
2023-12-21 $2.69 $2.69 $2.51 $2.64 581 228
2023-12-20 $2.69 $2.69 $2.50 $2.57 213 918
2023-12-19 $2.68 $2.77 $2.50 $2.60 351 385
2023-12-18 $2.69 $2.69 $2.50 $2.53 160 608
2023-12-15 $2.78 $2.78 $2.57 $2.65 221 860
2023-12-14 $2.81 $2.84 $2.65 $2.65 216 543
2023-12-13 $2.63 $2.90 $2.63 $2.75 550 884
2023-12-12 $2.52 $2.66 $2.43 $2.62 190 654
2023-12-11 $2.66 $2.66 $2.42 $2.58 236 415
2023-12-08 $2.51 $2.65 $2.47 $2.65 309 149
2023-12-07 $2.50 $2.57 $2.40 $2.51 149 442
2023-12-06 $2.55 $2.62 $2.45 $2.55 110 915
2023-12-05 $2.51 $2.64 $2.44 $2.55 123 302
2023-12-04 $2.56 $2.58 $2.40 $2.50 120 671
2023-12-01 $2.47 $2.59 $2.39 $2.57 271 307
2023-11-30 $2.21 $2.51 $2.21 $2.47 344 925
2023-11-29 $2.23 $2.29 $2.18 $2.24 167 915
2023-11-28 $2.16 $2.25 $2.12 $2.23 115 400
2023-11-27 $2.10 $2.19 $2.10 $2.14 152 958
2023-11-24 $2.22 $2.22 $2.10 $2.10 114 234
2023-11-22 $2.11 $2.23 $2.10 $2.20 117 153
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT